您的位置: 首页 > 农业专利 > 详情页

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
专利权人:
The Trustees Of The University Of Pennsylvania;US University of Pittsburgh - Of the Commonwealth System of Higher Education;Novartis AG
发明人:
BROGDON, Jennifer,LOEW, Andreas,JOHNSON, Laura Alexandra,JUNE, Carl H.,MAUS, Marcela,SCHOLLER, John,OKADA, Hideho
申请号:
DK14713280
公开号:
DK2958943T3
申请日:
2014.02.20
申请国别(地区):
DK
年份:
2019
代理人:
摘要:
The invention provides compositions and methods for treating diseases associated with expression of EGFRvIII. The invention also relates to chimeric antigen receptor (CAR) specific to EGFRvIII, vectors encoding the same, and recombinant T cells comprising the anti-EGFRvIII CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an anti-EGFRvIII binding domain.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充